StockClub
CRSPCRISPR Therapeutics AG$ --
CRISPR Therapeutics AG

CRISPR Therapeutics AG

CRSP

$ -

-

You can review balance sheet highlights, composition, equity ratio trends, and annual balance sheet line items.

account_balanceBalance Sheet (BS) Summary

2025/12 Filed: 2026-02-12

Total Assets

account_balance
2.3B USD
No comparison

Shareholders' Equity

savings
1.9B USD
No comparison

Equity Ratio

pie_chart
84.8%
No comparison

Book Value Per Share

paid
21.37USD
No comparison

Asset & Liability Mix

Non-current AssetsCurrent AssetsEquityNon-current LiabilitiesCurrent Liabilities

Equity Ratio Trend (5 Years)

Unit: %
200150100500
2021
2022
2023
2024
2025

Balance Sheet Details

Item
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Cash
Cash and Equivalents
Short-term Investments
Net Receivables
Inventory
Other Current Assets
Total Current Assets
355.19M
355.19M
1.63B
0
0
9.84M
1.99B
Goodwill
Intangible Assets
Property, Plant and Equipment
Property, Plant and Equipment Net
Long-term Investments
Other Assets
Other Non-current Assets
Net Tangible Assets
Non-current Assets Total
Total Assets
0
0
247.57M
247.57M
0
0
32.00M
2.27B
279.57M
2.27B
Accounts Payable
Short-term Debt
Short/Current Long-term Debt
Current Deferred Revenue
Other Current Liabilities
Total Current Liabilities
11.14M
18.58M
18.58M
15.77M
89.55M
149.12M
Long-term Debt
Long-term Debt Total
Capital Lease Obligations
Other Non-current Liabilities
Net Debt
Non-current Liabilities Total
Total Liabilities
188.17M
394.91M
188.17M
-182.03M
39.73M
194.31M
343.43M
Common Stock
Common Stock Shares Outstanding
Additional Paid-in Capital
Retained Earnings
Accumulated Other Comprehensive Income
Other Stockholder Equity
Treasury Stock
Total Stockholder Equity
3.09M
89.93M
3.86B
-1.95B
4.82M
0
-60,000
1.92B

Unlock Long-Term Balance Sheet Data

Your current plan allows viewing financial data for the latest 1 year (annual only). Upgrade to the Standard Plan to view up to 3 years (including quarterly data), or the Premium Plan to access all historical data.